ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...

Experts predicted that artificial intelligence would steal radiology jobs. But at the Mayo Clinic, the technology has been ...

The very same digital supply chain strategies that help companies mitigate ESG risks can also unlock powerful, data-driven ...

Consumers must understand how user-friendly features, tailored data options, and expanding network technologies like 5G can ...

With its latest product release that was showcased at its annual customer conference, ICON 2025, Blue Yonder delivers several artificial intelligence (AI)-infused Cognitive Solutions, accelerating ...

Blue Yonder unveils five domain-specific AI agents at ICON 2025, culminating CEO Duncan Angove's three-year, $2 billion ...

Gemini in Sheets isn't just another layer of complexity. It's a seamless upgrade built right into your workflow. Unlike ...

Residents in and around Bessemer are furious over Project Marvel, a plan to build a 4.5-million-square-foot data processing ...

The increasing demand for advanced medical technologies and ongoing innovations has intensified the requirement for specialized regulatory expertise. VANCOUVER, BRITISH COLUMBIA, CANADA, May 13, 2025 ...

Blue Yonder, the world leader in end-to-end digital supply chain transformation, launched several new solutions and showcased its vision to build the supply chain of the future at ICON 2025, its ...

Supply chain meets agentic tech - how Cognitive Solutions set out to address a pressing need in today's turbulent economic climate.

Results of the landmark MIROCALS clinical trial, published in The Lancet, show a low-dose interleukin-2 (IL2LD) is safe, ...